Biolife Solutions BLFS
NASDAQ BLFS
$34.92 -0.01 (-0.03%)
As of: Sep 10, 2026 · 3:59 PM EDT

Biolife Solutions (BLFS) Notes Payables (2016 - 2020)

Biolife Solutions' (BLFS) quarterly Notes Payables came in at $2.8 million in Q4 2020, up 45.25% quarter-over-quarter from $1.9 million in Q3 2020.

Analysis

Biolife Solutions (BLFS) Notes Payables (2016 - 2020) Analysis & Trends

Biolife Solutions (BLFS) has reported Notes Payables for 2 consecutive years, with $2.8 million the latest figure, recorded in Q4 2020.

  • On a quarterly basis, Notes Payables changed N/A year-over-year to $2.8 million in Q4 2020; TTM through Dec 2020 was $2.8 million, a N/A change from a year earlier, with the FY2020 full-year figure at $2.8 million, changed N/A from the prior year.
  • Notes Payables was $2.8 million for Q4 2020 at Biolife Solutions, up from $1.9 million in the prior quarter.
  • Over five years, Notes Payables peaked at $17.7 million in Q1 2020 and troughed at $656809.0 in Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn
10 Biolife Solutions 1.71 Bn 1.62 Bn 18.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2.78 Mn
Sep 30, 2020 1.91 Mn
Jun 30, 2020 963,000.00
Mar 31, 2020 17.67 Mn
Dec 31, 2016 2.84 Mn
Sep 30, 2016 1.75 Mn
Jun 30, 2016 656,809.00